Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 May;92(5):554-61.
doi: 10.1111/j.1349-7006.2001.tb01129.x.

CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNA in mouse liver

Affiliations

CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNA in mouse liver

M Shimizu et al. Jpn J Cancer Res. 2001 May.

Abstract

Combination chemotherapy consisting of 5-fluorouracil (5-FU) and 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carboxycamptothecin (CPT-11) is a promising regimen for gastrointestinal cancer. The circadian-dependent efficacy and toxicity of 5-FU are related to the circadian variation in the activity of dihydropyrimidine dehydrogenase (DPD), which is a rate-limiting enzyme in the pyrimidine catabolic pathway. To optimize the schedule of the CPT-11 plus 5-FU combination, we investigated the effect of CPT-11 on the circadian rhythm of DPD in vivo. In control mice, the DPD mRNA level in the liver was significantly higher at 14:00 than that at 02:00. After intravenous administration of CPT-11 (30 mg / kg) at 20:00, the circadian rhythm of the DPD mRNA level in the liver was no longer observed 18 h later (14:00), but it was unaffected 6 and 18 h later (at 14:00 and 02:00) when CPT-11 was given at 08:00. In addition, a dose-dependent lengthening of the period of the circadian rhythm of DPD was observed for 42 h after intravenous injection of CPT-11 at 20:00. The levels of DPD protein and activity at 21 h after administration of CPT-11 (at 17:00) were significantly higher than at 9 h (at 05:00). These results suggest that CPT-11 may influence the circadian rhythm of DPD at the transcriptional level. Modulation of the circadian rhythm of DPD by CPT-11 may be a factor in optimizing the combination of 5-FU and CPT-11.

PubMed Disclaimer

References

    1. Kojima , A. , Shinkai , T. and Saijo , N . Cytogenetic effects of CPT‐11 and its active metabolite, SN‐38 on human lymphocytes . Jpn. J. Clin. Oncol 23 , 116 – 122 ( 1993. ). - PubMed
    1. Conti , J. A. , Kemeny , N. E. , Saltz , L. B. , Huang , Y. , Tong , W. P. , Chou , T. C. , Sun , M. , Pulliam , S. and Gonzalez , C.Irinotecan is an active agent in untreated patients with meta‐static colorectal cancer . J. Clin. Oncol 14 , 709 – 715 ( 1996. ). - PubMed
    1. Vanhoefer , U. , Harstrick , A. , Kohne , C. H. , Achterrath , W. , Rustum , Y. M. , Seeber , S. and Wilke , H . Phase I study of a weekly schedule of irinotecan, high‐dose leucovorin, and infusional fluorouracil as first‐line chemotherapy in patients with advanced colorectal cancer . J. Clin. Oncol , 17 , 907 – 913 ( 1999. ). - PubMed
    1. Ducreux , M. , Ychou , M. , Seitz , J. F. , Bonnay , M. , Bexon , A. , Armand , J. P. , Mahjoubi , M. , Mery‐Mignard , D. and Rougier , P . Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high‐dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose‐finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer . J.Clin. Oncol 17 , 2901 – 2908 ( 1999. ). - PubMed
    1. Saltz , L. B. , Cox , J. V. , Blanke , C. , Rosen , L. S. , Fehrenbacher , L. , Moore , M. J. , Maroun , J. A. , Ackland , S. P. , Locker , P. K. , Pirotta , N. , Elfring , G. L. and Miller , L. L . Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group . N. Engl. J. Med 343 , 905 – 914 ( 2000. ). - PubMed

Publication types

MeSH terms

LinkOut - more resources